270 related articles for article (PubMed ID: 2097084)
1. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.
Sloane BF; Moin K; Krepela E; Rozhin J
Cancer Metastasis Rev; 1990 Dec; 9(4):333-52. PubMed ID: 2097084
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B and cystatins: evidence for a role in cancer progression.
Sloane BF
Semin Cancer Biol; 1990 Apr; 1(2):137-52. PubMed ID: 2103490
[TBL] [Abstract][Full Text] [Related]
3. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.
Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT
Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation.
Corticchiato O; Cajot JF; Abrahamson M; Chan SJ; Keppler D; Sordat B
Int J Cancer; 1992 Oct; 52(4):645-52. PubMed ID: 1399147
[TBL] [Abstract][Full Text] [Related]
6. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy.
Calkins CC; Sameni M; Koblinski J; Sloane BF; Moin K
J Histochem Cytochem; 1998 Jun; 46(6):745-51. PubMed ID: 9603786
[TBL] [Abstract][Full Text] [Related]
7. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
8. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
9. Cathepsins B and L are markers for clinically invasive types of meningiomas.
Strojnik T; Zidanik B; Kos J; Lah TT
Neurosurgery; 2001 Mar; 48(3):598-605. PubMed ID: 11270551
[TBL] [Abstract][Full Text] [Related]
10. Degradation of laminin by human tumor cathepsin B.
Lah TT; Buck MR; Honn KV; Crissman JD; Rao NC; Liotta LA; Sloane BF
Clin Exp Metastasis; 1989; 7(4):461-8. PubMed ID: 2785014
[TBL] [Abstract][Full Text] [Related]
11. The current stage of cathepsin B inhibitors as potential anticancer agents.
Kos J; Mitrović A; Mirković B
Future Med Chem; 2014 Jul; 6(11):1355-71. PubMed ID: 25163003
[TBL] [Abstract][Full Text] [Related]
12. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
Rozhin J; Robinson D; Stevens MA; Lah TT; Honn KV; Ryan RE; Sloane BF
Cancer Res; 1987 Dec; 47(24 Pt 1):6620-8. PubMed ID: 2824039
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
Rozhin J; Gomez AP; Ziegler GH; Nelson KK; Chang YS; Fong D; Onoda JM; Honn KV; Sloane BF
Cancer Res; 1990 Oct; 50(19):6278-84. PubMed ID: 2400991
[TBL] [Abstract][Full Text] [Related]
14. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors.
Bervar A; Zajc I; Sever N; Katunuma N; Sloane BF; Lah TT
Biol Chem; 2003 Mar; 384(3):447-55. PubMed ID: 12715895
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin B and its inhibitor stefin A in brain tumors.
Strojnik T; Zajc I; Bervar A; Zidanik B; Golouh R; Kos J; Dolenc V; Lah T
Pflugers Arch; 2000; 439(3 Suppl):R122-3. PubMed ID: 10653164
[TBL] [Abstract][Full Text] [Related]
16. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
17. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C.
Coulibaly S; Schwihla H; Abrahamson M; Albini A; Cerni C; Clark JL; Ng KM; Katunuma N; Schlappack O; Glössl J; Mach L
Int J Cancer; 1999 Nov; 83(4):526-31. PubMed ID: 10508490
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.
Spiess E; Brüning A; Gack S; Ulbricht B; Spring H; Trefz G; Ebert W
J Histochem Cytochem; 1994 Jul; 42(7):917-29. PubMed ID: 8014475
[TBL] [Abstract][Full Text] [Related]
19. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
20. Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro.
Sever N; Filipic M; Brzin J; Lah TT
Biol Chem; 2002 May; 383(5):839-42. PubMed ID: 12108549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
